Sarcoma trials in China

In China 106 Also abroad 605

106 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
Evaluate the Safety and Clinical Activity of HH2853
Where
Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Hefei, Linyi, Nanjing, Nanning, Shanghai, Shenyang, Taiyuan, Tianjin, Wuhan, Zhengzhou
Age
18 years and over
People
254 worldwide
Run by
Haihe Biopharma Co., Ltd.
See details and how to joinNCT04390737
Phase 2Taking people
MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced Sarcoma
Where
Shanghai
Age
12 years to 70 years
People
46
Run by
Shanghai 6th People's Hospital
See details and how to joinNCT07359053
Phase 2Not yet taking people in China
A Clinical Study on the Efficacy and Safety of All-trans Retinoic Acid Combined With VAC Regimen in the Treatment of Intermediate-to-high-risk Rhabdomyosarcoma
Where
Shanghai
Age
14 years to 60 years
People
106
Run by
Fudan University
See details and how to joinNCT07355855
Phase 2Not yet taking people in China
A Prospective, Multicenter, Open-label, Single-arm Phase II Clinical Study Evaluating the Efficacy and Safety of Spatially Fractionated Radiotherapy Combined With the PraG Strategy for the Treatment of Soft Tissue Sarcoma
Where
Nanning
Age
18 years to 75 years
People
25
Run by
First Affiliated Hospital of Guangxi Medical University
See details and how to joinNCT07342322
Early phase 1Not yet taking people in China
TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors
Where
Guangzhou
Age
18 years to 75 years
People
25
Run by
Sun Yat-sen University
See details and how to joinNCT07342738
Phase 2Taking people
IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)
Where
Shanghai
Age
18 years to 75 years
People
45
Run by
Fudan University
See details and how to joinNCT06849986
No phaseTaking people
Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01)
Where
Beijing
Age
18 years and over
People
50
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT05224934
Phase 2Taking people
QL1706 in the Treatment of Advanced Bone and Soft Tissue Sarcoma
Where
Guangzhou
Age
18 years to 75 years
People
45
Run by
Sun Yat-sen University
See details and how to joinNCT06939855
Phase 1/2Taking people
A Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation
Where
Hangzhou, Nanning, Shanghai, Wuhan, Zhengzhou
Age
18 years and over
People
152
Run by
Ranok Therapeutics (Hangzhou) Co., Ltd.
See details and how to joinNCT06667544
Phase 2Taking people
Vebreltinib for Advanced or Metastatic CCS
Where
Hangzhou
Age
12 years and over
People
30
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07153887
Phase 2Not yet taking people in China
A Prospective, Single-arm, Multicenter Exploratory Clinical Study of Anlotinib Combined With Bempegaldesleukin and Conventional Chemoradiotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma.
Where
Nanjing
Age
18 years to 80 years
People
46
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07156643
Phase 1Taking people
An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors
Where
Guangzhou
Age
18 years to 75 years
People
15
Run by
Guangzhou FineImmune Biotechnology Co., LTD.
See details and how to joinNCT06942143
Phase 2Not yet taking people in China
Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients
Where
Shanghai
Age
12 years to 70 years
People
23
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07142863
Phase 2Taking people
Ivonescimab in the Treatment of Multiple Advanced Tumors
Where
Shanghai
Age
18 years and over
People
400
Run by
Fudan University
See details and how to joinNCT06683846
Phase 1Taking people
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
Where
Zhengzhou
Age
18 years to 75 years
People
21
Run by
GONGCHU Biotechnology Co., Ltd
See details and how to joinNCT06508307
Phase 2Taking people
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
Where
Guangzhou
Age
18 years to 70 years
People
148
Run by
HRYZ Biotech Co.
See details and how to joinNCT06277154
Phase 2Taking people
A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma
Where
Wuhan
Age
18 years to 75 years
People
53
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06367075
Phase 1/2Taking people
Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer
Where
Beijing
Age
21 years to 90 years
People
80
Run by
Essen Biotech
See details and how to joinNCT07067255
Phase 1/2Taking people
Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas
Where
Beijing
Age
21 years to 90 years
People
60
Run by
Essen Biotech
See details and how to joinNCT07066982
Phase 2Taking people
VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma
Where
Shanghai
Age
18 years to 65 years
People
48
Run by
Ruijin Hospital
See details and how to joinNCT07028086
Phase 2Taking people
Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma
Where
Guangzhou
Age
18 years to 75 years
People
29
Run by
Sun Yat-sen University
See details and how to joinNCT06827717
Phase 2Taking people
BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma
Where
Shanghai
Age
8 years to 65 years
People
30
Run by
Ruijin Hospital
See details and how to joinNCT04072042
Phase 2Taking people
Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma
Where
Guangzhou
Age
18 years and over
People
32
Run by
Fujun Zhang
See details and how to joinNCT05894018
No phaseTaking people
Umbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study
Where
Dongguan, Guangzhou
Age
Up to 18 years
People
40
Run by
Sun Yat-sen University
See details and how to joinNCT06848582
Phase 1/2Taking people
APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors
Where
Guangzhou, Hangzhou, Shanghai
Age
18 years and over
People
95
Run by
Ascentage Pharma Group Inc.
See details and how to joinNCT04785196